Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1669.20
-31.35 (-1.84%)
< Home < Back

Sun Pharmaceutical Industries gets HC nod for scheme of arrangement

Date: 20-05-2013

Sun Pharmaceutical Industries has received an approval from High Court of Gujarat and Mumbai on May 03, 2013 for scheme of arrangement between Sun Pharmaceutical Industries (SPIL) and Sun Pharma Laboratories (SPLL) in the nature of Spin-Off and transfer of Domestic Formulation Business/Undertaking of SPIL to SPLL with effect from the appointed date of March 31, 2012.

Further the certified copies of the High Court orders will be filed with the Registrar of Companies shortly as required and the spin off process would get completed.

Sun Pharmaceuticals Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.